How Useful Are International Treatment Guidelines in Low- and Middle-Income Countries?
- PMID: 29094081
- PMCID: PMC5646903
- DOI: 10.1200/JGO.2016.008250
How Useful Are International Treatment Guidelines in Low- and Middle-Income Countries?
Conflict of interest statement
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/site/ifc.Stewart KerrNo relationship to discloseAbdul-Rahman JaziehNo relationship to discloseDavid KerrEmployment: Oxford Cancer Biomarkers Stock or Other Ownership: Oxford Cancer Biomarkers, Celleron Therapeutics, OxOnc Research Funding: Roche (Inst) Patents, Royalties, Other Intellectual Property: Patent on chemotoxicity single nucleotide polymorphisms (Inst)
References
-
- American Society of Clinical Oncology: Guidelines, tools, and resources. http://www.asco.org/practice-guidelines/quality-guidelines/guidelines.
-
- National Comprehensive Cancer Network: NCCN Guidelines. https://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp.
-
- European Society for Medical Oncology: ESMO clinical practice guidelines. http://www.esmo.org/Guidelines.
-
- Kerr DJ, Midgley R. Can we treat cancer for a dollar a day? Guidelines for low-income countries. N Engl J Med. 2010;363:801–803. - PubMed
-
- Gray M, Kerr DJ. How to Get Better Value Cancer Care. Oxford, UK: Offox Press; 2013.
LinkOut - more resources
Full Text Sources
Other Literature Sources